Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GE HealthCare TechnologiesMEX:GEHC -4.17%67 EV-to-EBITDA is 10.31 as of Aug. 02, 2026, which is 13% below its 10-year median of 11.89. GuruFocus rates MEX:GEHC with a GF Score™ of 67/100 and a GF Value™ of MXN1,421.18 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 512 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 64.26% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, GE HealthCare Technologies's enterprise value is MXN684,062 Mil.
GE HealthCare Technologies's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was MXN66,336 Mil. Therefore, GE HealthCare Technologies's EV-to-EBITDA for today is 10.31.
The historical rank and industry rank for GE HealthCare Technologies's EV-to-EBITDA or its related term are showing as below:
MEX:GEHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.89 Med: 11.89 Max: 14.45
Current: 10.67
During the past 7 years, the highest EV-to-EBITDA of GE HealthCare Technologies was 14.45. The lowest was 7.89. And the median was 11.89.
MEX:GEHC's EV-to-EBITDA is ranked better than 64.26% of 512
companies
in the Medical Devices & Instruments industry
Industry Median: 14.39
vs MEX:GEHC: 10.67
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
GE HealthCare Technologies (MEX:GEHC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GE HealthCare Technologies's PE Ratio (TTM) for today is calculated as:
GE HealthCare Technologies's share price for today is MXN1150.00.
GE HealthCare Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN78.075.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GEHC vs DXCM, STE, ZBH: EV-to-EBITDA Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's EV-to-EBITDA falls into.
GE HealthCare Technologies's current Enterprise Value is MXN684,062 Mil.
GE HealthCare Technologies's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN66,336 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (MEX:GEHC) has a EV-to-EBITDA of 10.31 as of Aug. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on GE HealthCare Technologies. This is 13% below median its historical median of 11.89. Over the past decade, GE HealthCare Technologies' EV-to-EBITDA has ranged from 7.89 to 14.45. According to the industry distribution chart, GE HealthCare Technologies ranks #183 out of 512 companies in the Medical Devices & Instruments industry, placing it in the top 35.7%.
Is GE HealthCare Technologies' EV-to-EBITDA too high?
GE HealthCare Technologies' current EV-to-EBITDA of 10.31 is 13% below median its 10-year median of 11.89. Over the past 10 years, this metric has ranged from a low of 7.89 to a high of 14.45. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.39. GE HealthCare Technologies' value of 10.31 is 28.4% below this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #183 out of 512 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, GE HealthCare Technologies has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' EV-to-EBITDA compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #183 out of 512 companies for EV-to-EBITDA. This puts GE HealthCare Technologies in the upper half of its industry. The industry median EV-to-EBITDA is 14.39. GE HealthCare Technologies' value of 10.31 is 28.4% below this benchmark. Historically, GE HealthCare Technologies' own EV-to-EBITDA has ranged from 7.89 to 14.45 over the past decade. While the company's 10-year median is 11.89 vs. the industry median of 14.39, GE HealthCare Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.39, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current EV-to-EBITDA of 10.31 is 28.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on GE HealthCare Technologies. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current EV-to-EBITDA is 10.31, which is 13% below median its own 10-year median of 11.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,421.18, compared to a current price of MXN1,150.00 — trading 19.1% below its estimated fair value. The current EV-to-EBITDA is 10.31, which is 13% below median its 10-year median of 11.89 and 28.4% below the Medical Devices & Instruments industry median of 14.39. GE HealthCare Technologies' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current EV-to-EBITDA is 10.31 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of MXN1,150.00 is trading 19.1% below its estimated GF Value™ of MXN1,421.18.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for MEX:GEHC:
EV-to-EBITDA: 10.31 (13% below median its 10-year median of 11.89)
GF Value™: MXN1,421.18 vs. price of MXN1,150.00 (19.1% below fair value)
Industry Position: 28.4% below the Medical Devices & Instruments median (#183 of 512)
No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
67GF Score
Get the complete analysis for MEX:GEHC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GEHC has been successfully added to your 
